Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status

PaperCitations, authors & open-access status

Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 13 citations, 2022 year and gold oa status.

13
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Francesco Pavese
Author
Cancers
Journal
HER2/EGFR in Cancer Research
Topic
HER2/EGFR in Cancer Research
Topic
Breast Cancer Treatment Studies
Topic
Cancer Treatment and Pharmacology
Topic
470M+ articles · free account